寻常型天疱疮皮损中藏匿着抗桥粒芯蛋白3反应性B细胞
寻常型天疱疮由抗桥粒芯蛋白3(Dsg3)IgG自身抗体致病,既往认为自身反应性B细胞在脾和淋巴结等次级淋巴器官中定居并产生抗体。Yuan等采用多种实验技术分析患者皮损中的淋巴细胞,发现皮损中存在Dsg3反应性B细胞,扩展了对天疱疮发病机制的认识,并提示在随访皮损和考虑辅助治疗时需加以关注。
要点
- 寻常型天疱疮皮损中存在Dsg3反应性B细胞。
- 自身反应性B细胞并非仅局限于次级淋巴器官。
- 该发现对随访皮损和辅助治疗决策有提示意义。
核心结论
- 寻常型天疱疮患者皮损中存在桥粒芯蛋白3反应性B细胞,扩展了对该病发病机制的理解。
研究设计与样本
- Yuan等采用多种实验技术分析寻常型天疱疮患者皮损中的淋巴细胞。
主要发现
- 分析结果显示寻常型天疱疮皮损中存在桥粒芯蛋白3反应性B细胞。
临床怎么用
- 在随访天疱疮皮损临床病程和考虑辅助治疗时,应考虑皮损中可能存在桥粒芯蛋白3反应性B细胞这一发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pemphigus vulgaris is an autoimmune blistering disease caused by anti-desmoglein 3 IgG autoantibodies. It is accepted that interactions between autoreactive B and T cells are key to humoral autoimmunity targeting desmoglein 3. This orchestrated process usually occurs in secondary lymphoid organs, including the spleen and lymph nodes. Thus, it seems likely that autoreactive B cells reside and produce autoantibodies in these tissues. Yuan et al. analyzed lymphocytes in the lesional skin of patients with pemphigus vulgaris using several experimental techniques and concluded that desmoglein 3-reactive B cells were present. This finding expands our understanding of the pathogenesis of pemphigus and should be considered when following the clinical course of skin lesions and thinking about adjunctive therapy.
引用
- Takahashi H. Desmoglein 3-Reactive B Cells "Hiding" in Pemphigus Lesions. J Invest Dermatol. 2017. PMID: 29055412. doi:10.1016/j.jid.2017.07.823
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。